Bone scan and bone biopsy in the detection of skeletal metastases

Oncology Reports

Volumn 6, Issue 1, 1999, Pages 185-188

  Ron, Ilan G ^a,b   Striecker, Avi ^a,c   Lerman, Hedva ^a   Bar Am, Amiram ^a   Frisch, Bertha ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Bone marrow biopsy; Bone metastases; Bone scan

Indexed keywords

DIAGNOSTIC AGENT; MEDRONATE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BIOPSY; BONE MARROW; BONE MARROW EXAMINATION; BONE TUMOR; DOUBLE BLIND PROCEDURE; EVALUATION; FEMALE; HUMAN; ILIAC BONE; LABORATORY DIAGNOSIS; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TIME;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BONE MARROW; BONE MARROW EXAMINATION; BONE NEOPLASMS; DOUBLE-BLIND METHOD; EVALUATION STUDIES; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; ILIUM; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M MEDRONATE; TIME FACTORS;

EID: 0032608284     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.6.1.185     Document Type: Article

References (31)

1. Kamby C, Vejborg I, Daugaard S, et al: Clinical and radiologic characteristics of bone metastases in breast cancer. Cancer 60: 2524-2531, 1987.
2. Milleron BJ, Le Breton C, Carette MF, et al: Assessment of bone marrow involvement by magnetic resonance imaging in small cell lung cancer. No significant change of staging. Chest 106: 1030-1035, 1994.
3. Perrin-Resche I, Bizais Y, Buhe T, et al: How does iliac crest bone marrow biopsy compare with imaging in the detection of bone metastases in small cell lung cancer? Ear J Nucl Med 20: 420-425, 1993.
4. O'Donoghue JM, Rogers E, Grimes H, et al: A reappraisal of serial isotope bone scans in prostate cancer. Br J Radiol 66: 672-676, 1993.
5. Coombes RC, Dearnaley DP, Buckman R, et al: Detection of bone metastases in patients with breast cancer. Invasion Metastasis 2: 177-184, 1982.
6. Gold RH and Bassett LW: Radionuclide evaluation of skeletal metastases: practical considerations. Skeletal Radiol 15: 1-9, 1986.
7. Prasad R and Olson WH: Bone marking for biopsy using radionuclide bone imaging. Cancer 60: 2205-2207, 1987.
8. Larar GN, Janicek MJ and Kaplan WD: Ga-67 scintigraphy after bone marrow harvest. Significance of 'sacroiliac' asymmetry in lymphoma patient. Clin Nucl Med 18: 126-129, 1993.
9. Feremans W. Bujan W, Neve P, et al: CD71 phenotype and the value of gallium imaging in lymphomas. Am J Hematol 36: 215-216, 1991.
10. Lee KH, Chung JK, Jeong JM, et al: Technetium 99-m-labeled antigranulocyte antibody bone marrow scintigraphy. J Nucl Med 36: 1880-1885, 1995.
11. 99Tc-MDP in patients with small cell lung cancer, with special reference to bone marrow and hepatic metastasis. Eur J Nucl Med 16: 717-719, 1990.
12. Gold RI, Sceger LL, Bassett LW, et al: An integrated approach to the evaluation of metastatic bone disease. Radiol Clin North Am 28: 471-483, 1990.
13. Frisch B, Bartl R, Mahl G, et al: Scope and value of bone marrow biopsies in metastatic cancer. Invasion Metastases 4 (Suppl.): 12-30, 1984.
14. Coleman R: Incidence and distribution of bone metastases. In: Metastatic Bone Disease, Fundamental and Clinical Aspects. Diel IJ. Kaufman M and Bastert G (eds). Sprinaer-Verlag, Berlin, 1994.
15. Bartl R and Frisch B: Metastatic bone diseases. In: Biopsy of Bone in Internal Medicine. An Atlas and Source Book Vol 21. Norwell MA (ed). Kluwer Academic Publishers. pp216-232, 1993.
16. Faugere MC and Malluche HH: Comparison of different bone biopsy techniques for qualitative and quantitative diagnosis of metabolic bone disease. J Bone Joint Surg 65: 1314-1318, 1983.
17. Harrington KD: Orthopaedic Management of Metastatic Bone Disease. Mosby, St. Louis, 1988.
18. Hortobagyi GN, Libshitz HI and Seabold JE: Osseous metastases of breast cancer. Clinical, biochemical, radiographic and scintisraphic evaluation of response to therapy. Cancer 51: 577-582, 1984.
19. Frisch B, Bartl R and Burkhardt R: Bone marrow biopsy in clinical medicine: an overview. Haematologia 3: 245-285, 1982.
20. Kastendieck H: Prostatic carcinoma: aspects of pathology, prognosis and therapy. J Cancer Res Clin Oncol 96: 131-156, 1980.
21. Landys K: Prognostic value of bone marrow biopsy in breast cancer. Cancer 49: 513-518, 1982.
22. Redding WH, Monaghau P, Imne SF, et al: Detection of micro-metastases in patients with primary breast cancer. Lancet II: 1971-1983, 1983.
23. Galasko CSB: Skeletal metastasis. Clin Orthop 210: 18-30, 1986.
24. Ell PJ, Dixon HJ and Abdullah AZ: Unusual spread of juxta cortical osteosarcoma. J Nucl Med 21: 190-191, 1980.
25. Moores DW, Line B, Dziuban SW Jr, et al: Nuclear scan-guided rib biopsy. J Thorac Cardiovasc Surg 99: 620-162, 1990.
26. Rappaport AH, Hoffer PB and Genant HK: Unifocal bone findings by scintigraphy, clinical significance in patients with known primary cancer. West J Med 129: 188-192, 1978.
27. Collins JD, Bassett L, Main CD, et al: Percutaneous biopsy following positive bone scans. Radiology 132: 439-442, 1979.
28. Tyler JL and Powers TA: Bone scanning after marrow biopsy: concise communication. J Nucl Med 23: 1085-1087, 1982.
29. Meinshausen J, Chovitz H and Georgii A: Frequency of skeletal metastasis as revealed by routinely taken bone marrow biopsies. Virchows Arch (A) 389: 409-417, 1980
30. Kamby C, Guldhammer B, Vejborg I, et al: The presence of tumor cells in bone marrow at the time of first recurrence of breast cancer. Cancer 60: 1307-1312, 1987.
31. Gulenchyn KY and Papoff W: Technetium-99m-MDP scintigraphy - an insensitive tool for the detection of bone marrow metastases. Clin Nucl Med 12: 45-46, 1987.